Stay updated on FF-10101-01 Study in Relapsed AML Clinical Trial
Sign up to get notified when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.

Latest updates to the FF-10101-01 Study in Relapsed AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page displays Revision: v3.4.2, replacing Revision: v3.4.1.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page. This seems to be a minor site update and does not modify study information.SummaryDifference0.0%

- Check84 days agoChange DetectedThe revision label on the page was updated from v3.3.3 to v3.3.4. No study content or page behavior appears to be altered.SummaryDifference0.0%

- Check105 days agoChange DetectedA consolidated Locations section now lists study sites by state (CA, IL, MD, MA, NY, PA) instead of separate state headers, clarifying where the trial is conducted and improving site visibility.SummaryDifference0.7%

Stay in the know with updates to FF-10101-01 Study in Relapsed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.